TB-500

TB-500 is a synthetic version of the naturally occurring 43-amino acid peptide Thymosin Beta-4 (Tβ4), which is found in virtually all mammalian cells. Thymosin Beta-4 plays a fundamental role in cellular processes including actin polymerization, cell migration, and differentiation. As the primary intracellular G-actin sequestering peptide, it regulates actin dynamics that are critical for cell motility, organogenesis, and tissue-repair research models. Research interest in TB-500 centers on its activity in in-vitro wound-assay outcomes, inflammatory-marker modulation in preclinical studies, and tissue-remodeling research models.

Preclinical studies have characterized Thymosin Beta-4 in dermal and corneal epithelial cell-culture models, cardiac research models following myocardial ischemia induction, and central nervous system preclinical research models. The peptide upregulates the expression of laminin-5, a key component of the extracellular matrix, and promotes the migration of endothelial cells and keratinocytes in cell-migration kinetics studies. In cardiac preclinical research, Tβ4 has been shown to activate epicardium-derived progenitor cells and to modulate infarct-size parameters in rodent research models.

Additional research has explored TB-500's inflammatory-marker modulation profile. The peptide has been reported to downregulate pro-inflammatory cytokine markers and to modulate NF-κB signaling pathways. Studies in equine research models have investigated its effects on tendon and ligament preclinical-model parameters, while ophthalmic research has examined its activity in corneal epithelial cell-culture models. These findings suggest a multifaceted mechanism of action extending across multiple tissue-repair research models.